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Summary 
The CD45 tyrosine phosphatase plays an important role in regulating T  lymphocyte activation, 
but the function of the different isoforms of CD45 is not known. T  cell transfectants have been 
prepared that  express individual  CD45  isoforms in  cells  with  a well-defined T  cell receptor 
(TCR) from the D10 T  helper 2 clone. We find that cells bearing low molecular weight CD45 
isoforms are far more efficient in responding to stimulation with peptide and antigen-present- 
ing cells  compared with cells bearing high molecular weight CD45 isoforms. One hypothesis 
for the preferential activation of cells that express low molecular weight CD45 isoforms is that 
they interact with other cell surface antigens important in TCR. signaling, altering their phos- 
phorylation status and affecting the character of the signal transduction pathway. In this report, 
using cells  expressing single isoforms, we demonstrate that low molecular weight isoforms of 
CD45 preferentially associate with CD4 and the TCR complex compared with high molecular 
weight isoforms. The molecular basis for this interaction was further examined using a glycosyl 
phosphatidyl inositol (GPI)-linked form of CD45Null  (lacking tyrosine phosphatase domains), 
which  preferentially associated with  CD4 compared with  GPI-linked CD45ABC,  and cyto- 
plasmic tail mutants of CD4, which retained the ability to coassociate. Using this panel of trans- 
fectants, it is clear that the interaction between CD4 and CD45 does not require the cytoplas- 
mic  domains  of CD45,  but  is  dependent  on  the  specific  external  domain  of the  various 
isoforms:  low  molecular weight  species were  more likely to  associate  with  the  CD4-TCR 
complex than the higher molecular weight isoforms, and their ability to coassociate correlated 
with the magnitude of the response to specific antigen. 
C 
D45  is  a  transmembrane  tyrosine  phosphatase  com- 
posed of a large heavily glycosylated extracellular por- 
tion that can exist as at least nine different isoforms generated 
by alternative tkNA splicing of exons 4-7. The expression 
of exons 4-6  are designated on the protein  as A, B,  and 
C,  respectively,  whereas  the  null  and  exon-1  forms  of 
CD45 do not contain exons 4-6 (CD45Null) or exons 4-7 
(CD45Ex-1). These isoforms range in molecular mass from 
~180  to 220 kD, and their expression is regulated during 
hematopoietic development and  on  different cell lineages 
(1,  2).  The  cytoplasmic portion  of CD45  functions  as  a 
protein tyrosine phosphatase  (PTPase) 1 and is essential for 
the generation of biochemical signaling events after stimu- 
lation of the TCP,. complex (3-6); however, the role of the 
different CD45 isoforms in T  cell activation is unknown. In 
1Abbreviations used in this paper: GPI, glycosyl phosphatidyl inositol; PI- 
PLC, phosphatidyl inositol-specific phospholipase C treatment; PTPase, 
protein tyrosine phosphatase. 
T  lymphocytes,  the  expression  of  different  isoforms  of 
CD45  is tightly regulated  during thymic development (7, 
8),  as well as  during  the generation and maturation of an 
immune response in the periphery (9-12).  Lower molecu- 
lar weight CD45 isoforms are preferentially expressed on T 
cells with a memory phenotype as defined by enhanced re- 
sponse to recall antigen, distinct patterns oflymphokine se- 
cretion,  and the  ability to provide help for B  cell Ig pro- 
duction  (9-12).  In  addition,  distinct  patterns  of  CD45 
isoform  expression  are  found  on  Thl  and  Th2  clones, 
which are defined by different patterns of cytokine produc- 
tion  (13).  The  correlation of different  CD45  isoform ex- 
pression with different stages of T  cell maturation and dif- 
ferent effector functions,  as well as the  known activity of 
CD45 in signal transduction pathways, raise the hypothesis 
that different isoforms of CD45 may selectively regulate the 
diverse outcomes possible after recognition  of antigen  by 
the TCR. 
To investigate the  role  of the  different CD45  isoforrns 
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system  has  been  developed  in  which  individual  isoform- 
specific cDNAs have been transfected into a  CD45-  mu- 
tant of the BW5147 thymoma. These cells  have been con- 
structed to express a TCR. of known specificity, and their 
response to peptide and allogeneic stimulation was investi- 
gated  (14).  These  studies  showed that  the  cells  expressing 
the  CD45Null  and  CD45C  isoforms  were  preferentially 
induced  to  secrete  IL-2  after  antigen-specific  stimulation 
compared with cells  expressing CD45ABC and CD45BC. 
These  data are similar to independent  results from Ong et 
al.  (15)  using transgenic  mice  that  overexpress  CD45Null 
or CD45ABC.  Thymocytes that constitutively expressed a 
CD45Null transgene  demonstrated an increased sensitivity 
to  antigen-specific  negative  selection  in  the  thymus  and 
TClZ-mediated  apoptosis  compared with  thymocytes that 
overexpressed  the  ABC  isoform.  It therefore  appears  that 
distinct isoforms of CD45 can differentially affect T  cell de- 
velopment and T  cell activation. 
One model to explain CD45 isoform-specific regulation 
of T  cell activation is that different isoforms of CD45 may 
preferentially coassociate in cis with other molecules on the 
T  cell  surface,  which  in  turn  may  directly  or  indirectly 
modulate the activity of the cytoplasmic tyrosine phospha- 
tase  domains  or their  access  to  different  substrates.  CD45 
has been described to associate with a variety of other mol- 
ecules  on the surface of the T  cell,  including CD2,  CD3, 
CD4,  Thy-1,  and  CD26  (16,  22).  The  association  with 
CD4 is  of particular  interest  since  the  CD4-associated ty- 
rosine kinase lck has been shown to be a potential substrate 
for  the  CD45  tyrosine  phosphatase  in  vitro  and  in  vivo 
(24-26).  The  association  of specific  CD45  isoforms  with 
CD4-1ck could increase lck activity by maintaining the de- 
phosphorylation  of  the  regulatory  COOH-terminal  ty- 
rosine  505.  Alternatively,  an  association  of  CD4  with 
CD45 before TCP,. signaling may prevent the access oflck 
to the  TCI< complex and prevent  the phosphorylation of 
TCP,. components (e.g., ~ chain), thus modifying the T  cell 
activation cascade. Previously published data from our lab- 
oratory have  suggested a  preferential  association  of CD45 
and CD4 after capping with anti-CD4  antibodies  on nor- 
mal  mouse  T  cells  and  with  Th  clones  (17).  Since  these 
cells  express a mixture  of CD45 isoforms,  a precise  deter- 
ruination  of which  isoforms  interact  with  CD4  was  not 
possible. 
In this report, we use an extensive panel of cell lines ex- 
pressing individual  CD45 isoforms to directly examine the 
effect of specific CD45 isoforms on the response to antigen 
stimulation  and  on  association  with  CD4  and  the  TCR.. 
These  results  indicate  that  responsiveness  to  antigen-spe- 
cific stimulation  is  directly correlated with  the  size of the 
CD45 isoform and that this directly parallels  the ability of 
specific  CD45  isoforms to  coassociate  with  CD4  and  the 
TCR..  The molecular basis  for CD4--CD45 interaction,  as 
well  as  the  requirement  for  CD45  PTPase  activity  and 
CD4-1ck  association  for  antigen-specific  stimulation,  was 
further  examined  using truncated  forms of CD45  lacking 
the  cytoplasmic  tyrosine  phosphatase  domains  and  CD4 
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mutants  that do not bind to lck. Using this panel of trans- 
fectants,  it  is  clear that  the  interaction  between  CD4  and 
CD45 does not require the cytoplasmic domains of CD45, 
but  is  dependent  on  the  specific  external  domain  of the 
various isoforms, with low molecular weight species more 
likely to  coassociate with  CD4 than  the  higher molecular 
weight isoforms. 
Materials  and Methods 
Generation of CD45  Transfectants.  A  CD45-  mutant  of the 
BW5147 AKR. thhymoma was generously provided by Dr. R.. Hy- 
man (The Salk Institute,  La Jolla,  CA). Before transfection  with 
CD45,  this  cell  line  was  reconstituted  with  the  CD3 ~  and 
chains  and the T  cell receptor ot and [3 chains  cloned from the 
D10.G4.1 Th2 cell clone, and also transfected with wild-type mu- 
rine CD4 as previously described  (14). This cell line  (BWTCP,/ 
CD4)  was then  either transfected  with intact  CD45 cDNAs or 
transfected with glycosyl phosphatidyl inositol (GPI)-linked  CD45. 
The  generation  of the  CD45ABC,  CD45BC,  CD45C,  and 
CD45Null  transfectants  have  been  described  previously  (14). 
eDNA encoding for the  CD45B  and  CD45Ex-1  isoforms  was 
obtained by PCR amplification  of BALB.k spleen eDNA using a 
forward  primer  5'-CGCAGTGCATGTAGCTAGCAACTG- 
GTTTG-3' encoding nucleotides 1-29 of CD45 mRNA (exon 
lb  form),  and  a  reverse  primer  5'-CTGTGAGCATTCTTC- 
TAGATTATTTAACACG-3' encoding nucleotides 880-850 of 
the ABC form ofCD45. PCR. products were digested with NheI 
and XbaI and separated on a 2% low-melt agarose gel (Seaplaque; 
FMC  Corp.,  Rockland,  ME).  Fragments  corresponding to sin- 
gle-exon forms and the Ex(-1)  form were excised  from the gel 
and cloned into XbaI-generated expression  vector pAR.V-I(H) 
(14).  Insert  orientation  was  determined  by  restriction  analysis. 
The identity of single-exon forms was determined by restriction 
analysis of PCR products generated using the internal  primers P1 
(in exon 2) and P2 (in exon 7) (13). Properly oriented B and Ex(-l) 
fragments were sequenced to verify their identity and ensure their 
correctness.  Clones with the correct sequence were digested with 
XbaI and ligated to a 3-kb XbaI fragment containing the remain- 
der of the CD45 coding region and a portion of the 3' untrans- 
lated region. 
The GPI-linked construct was prepared by insertion of the ex- 
tracellular domain of CD45 into the AvaI site of the pFP,  SV plas- 
mid containing the Thy-1 GPI linkage  described by Slanetz and 
Bothwell  (27). The  extracellular  coding portion  of CD45ABC 
and CD45Null was obtained by PCP, amplification  of the intact 
eDNA contained in the pARV-1  expression  vector (28), using 
primers  that  bracket  the  entire  extracellular  coding  region  of 
CD45 in the sequence described  by Thomas et al.  (29) (residues 
23-46,  5'-GCTCGAGTGTTCTTAGGGTAAGAGAG-Y; and 
residues  1801-1823,  5'-GCCCGAGGGTTTAGCATTAAA- 
ATTTGT-3').  This  construct was  linearized  by digestion  with 
SalI and ligated  to the pMCFP, plasmid  (linearized  with XhoI) 
containing the  gene  encoding resistance  to  hygromycin B.  All 
transfections  were  performed  by  electroporation  using  a  gene 
pulser  (Bio-l?,ad  Laboratories,  Hercules,  CA)  as previously de- 
scribed.  The  CD45  transfectants  were  selected  by resistance  to 
hygromycin and examined for CD45 expression and sensitivity to 
phosphatidyl  inositol~specific  phospholipase  C  treatment  (PI- 
PLC) by flow cytometric analysis. 
Generation of CD4 and CD8 Cell Lines.  CD4-rnutant retrovi- 
ral constructs  in the pMV7 vector were generously provided by 
T Cell Activation D.  Littman  (New  York  University)  and  were  used  to  infect 
CD4-  BWTcR. cells  that had previously been transfected with 
CD45Null.  The  following mutant  CD4  constructs were  used: 
CD4Ti  (cytoplasmic tail deletion)  (30),  MCA  1/2  (Cys to  Ala 
mutation in cytoplasmic tail)  (30),  and 4/8/4  (CD8  transmem- 
brane region) (Littman, D.R.,  unpublished data).  Retroviral in- 
fection using the xI*2 packing line and selection ofCD4 + cells by 
magnetic beads was carried out as described by Xu and Littman 
(31).  Ceils transfected with CD8ot were obtained by electropora- 
tion using the pSI:LoL  vector (14) and was selected with puromy- 
cin with cDNA generously provided by P. Kavathas (Yale Uni- 
versity). 
P1-PLC Treatment.  106  cells were  suspended  in  100  I*1  of 
RPMI  1640  supplemented with  10  mM  Hepes and incubated 
with  100  mU of PI-PLC  (Boehringer Mannheim Corp., India- 
napolis, IN) for 1 h at 37~  A parallel sample of cells was treated 
identically, except in the absence of PI-PLC. The cells were then 
labeled with anti-CD3, -CD4,  and -CD45 antibodies and were 
analyzed by flow cytometry to  evaluate specific removal of the 
GPI-linked CD45. 
Flow Cytometric Analysis.  The  following  anti-CD45  mAbs 
were used in this study: MI/9.3.4.HL.2, pan-specific anti-CD45 
(TIB122;  American Type  Culture  Collection  [ATCC],  Rock- 
ville,  MD);  14.8,  anti-CD45A  (TIB164;  ATCC);  C363.16A, 
anti-CD45B  (11);  C455.14F,  anti-CD45C  (Bottomly,  K.,  un- 
published data). In addition, anti-CD4 (GKI.5) (32) and an anti- 
clonotypic antibody for the D10 TCR (3D3)  (33) were also used. 
All antibodies were purified from culture supernatants on protein 
G  columns and dialyzed against PBS before use.  The cells were 
labeled with saturating amounts of the indicated antibody diluted 
in  PBS  supplemented with  1%  FCS  and  0.02%  sodium  azide 
(staining buffer) and incubated on ice for 30 min. The cells were 
then washed and incubated with FITC-conjugated goat anti-rat 
lgG or goat anti-mouse IgG (Hyclone Laboratories Inc., Logan, 
UT) for an additional 30 min on ice, and then washed and fixed 
in  PBS  with  1%  paraformaldehyde.  Fluorescence analysis  was 
done using a flow cytometer (FACScan|  Becton Dickinson & 
Co., Mountain View, CA), and the data were analyzed using the 
LYSYS II software package (Becton Dickinson & Co.). 
Cell Culture and IL-2 Production.  All cell lines were main- 
tained in Eagle's high amino acid medium (Click's medium; Irv- 
ine Sciencific, Santa Ana, CA) supplemented with 9% FCS, 5  ￿ 
10 -5 M  2-ME, 2 mM L-glutamine, 10 mM Hepes, and antibiot- 
ics. BW transfectants  in stable growth phase were stimulated for 2 d 
in culture in 96-well flat-bottom microtiter wells precoated with 
anticlonotypic TCR. mAb (3D3).  The cells were coated with dif- 
ferent dilutions of antibody in PBS for 4 h, washed, and 1-2 ￿ 
105 BW cells in 250 ~1 of media were added. In parallel, an equal 
number  of BW  transfectants were  stimulated with  conalbumin 
peptide (HR.GAIEWEGIESG) plus  106 T  cell-depleted spleno- 
cytes from B10.BR mice in round-bottom microtiter wells. After 
48  h,  the  supernatants  were  harvested  and  stored  frozen  at 
-20~  IL-2 production was determined using the IL-2-depen- 
dent CTLL-2 cell line. 104 CTLL cells were cultured in twofold 
dilutions of supernatant, and 48 h later the cells were pulsed with 
1 txCi [3H]thymidine. After 16-24 h the cells were harvested, and 
thymidine incorporation was  determined by liquid scintillation 
counting. 
Cocapping Assay.  106 BW cells were induced to cap by label- 
ing  with  either  biotinylated anti-CD4  (GK1.5)  or  anti-TCR 
(3D3)  for 30  min  in  a  37~  water bath.  The  cells  were  then 
washed  once  and  resuspended  in  streptavidin-PE  (CALTAG 
Laboratories, South San Francisco, CA) and incubated at 37~  for 
30 min for CD4 capping or 15 min for TCI< capping. The cells 
were then washed with ice-cold staining buffer and labeled with 
fluorescein-conjugated anti-CD45 or anti-CD3e antibodies (Phar- 
Mingen, San Diego, CA), and then fixed with 1% paraformalde- 
hyde in PBS. Control cells (labeled with PE or FITC alone) were 
always prepared simultaneously for each cell line to set compensa- 
tion parameters. 
Fluorescence  localization was  determined  using  a  scanning 
video laser cytometer (ACAS 570;  Meridian Instruments,  Inc., 
Okemos, MI) equipped with a 200-mW argon laser.  FITC and 
PE  fluorescence  was  simultaneously detected  using  a  575-nm 
short-pass dichroic filter followed by a 530-nm band-pass filter to 
detect FITC fluorescence and 605-nm long-pass (or in some ex- 
periments  575-nm  band-pass)  filter to  detect PE  fluorescence. 
Fluorescence cross-over was corrected for each cell line using the 
X-OVER.  compensation  software  package  (Meridian  Instru- 
ments,  Inc.)  using capped cells  singly labeled with  PE  or un- 
capped cells labeled with FITC-conjugated antibodies. For each 
experimental group, 100 capped cells were counted, and the per- 
centage of capped cells with coassociated CD45,  CD3,  or CD4 
was determined. 
Results 
Immunophenotype  of  CD45-transfected  Cell  Lines.  The 
CD45-  mutant of the BW5147 thymoma has been used to 
generate an extensive panel ofT cell lines that express indi- 
vidual CD45  isoforms, the CD4  coreceptor, and an MHC 
class II-restricted TCR  specific for a  conalbumin peptide. 
The cells are routinely sorted and subcloned to express similar 
levels of TCR,  CD4,  and CD45.  The immunophenotype 
of the  different cell lines is illustrated in  Fig.  1,  including 
surface labeling with antibodies specific for the CD45-vari- 
able  exons  A,  B,  or  C.  Cell lines expressing six different 
CD45  isoforms (CD45ABC,  CD45BC,  CD45B,  CD45C, 
CD45Null,  CD45Ex-1)  have  been  generated,  as  well  as 
cells bearing  truncated  and  mutated  forms  of CD45  and 
CD4.  Differential  isoform  expression  was  confirmed  by 
immunoprecipitation and  Western  blot analysis  (14,  Bot- 
tomly, unpublished data) in addition to the flow cytometric 
data presented in Fig. 1. 
CD45 Isoform Regulation of Antigen-induced IL-2 Production. 
Cells  expressing different  CD45  isoforms were  compared 
for their ability to secrete IL-2 after peptide plus APC stim- 
ulation and compared with maximal IL-2 production after 
stimulation with plate-bound anti-TCR, antibody (Fig. 2). 
Fig. 2 A  illustrates representative results from cells express- 
ing CD45ABC  and CD45Null. As we have previously de- 
scribed, both cell lines are able to produce similar levels of 
IL-2  after stimulation with  plate-bound anti-TCR  mAb, 
which is independent of the expression of CD4  or CD45 
(14). Although no difference was seen in response to plate- 
bound antibody, cells expressing the null isoform of CD45 
were preferentially stimulated after exposure to peptide and 
APC.  These  results  have  been  consistently observed after 
testing in multiple independently transfected cell lines (14). 
To determine ifCD45 isoform-specific regulation is corre- 
lated with the size of the isoform, or if cells expressing iso- 
forms of similar size show differential IL-2 production after 
251  Leitenberg et al. CD45neg 
CD45ABC 
CD45Null 
CD45Ex-1 
CD45C 
CD45B 
CD45BC 
anti-CD45(pan)  anti-CD45A 
LI!  ............. 
5_11 ........... 
antI-CD45B  antI-CD45C 
LI_ 
l_i_ 
l_ll  ..... 
Kt_ 
FLUORESCENCE  (Ioglo) 
antl-CD4  anti-TcR 
Figure  1.  Immunophenotype 
ofCD45 transfectants. The panel 
of BW transfectants was labeled 
with  antibodies  to  different 
CD45  isoforms, CD4,  and  the 
D10 TCIK, and analyzed  by flow 
cytometry.  Specific staining  is 
indicated by the solid histogram, 
background by the  open histo- 
gram. 
antigen  exposure,  we  have  extended  our  analysis  with  a 
panel of six different CD45 transfectants  (Fig.  2  B).  These 
results suggest that the ability to produce IL-2 after antigen 
stimulation is directly correlated with the size of the CD45 
isoform. Both of the single-exon forms (CD45B, CD45C), 
CD45Null, and CD45Ex-1, respond relatively well to anti- 
gen stimulation  compared with the cells  expressing higher 
molecular weight CD45 isoforms (CD45ABC, CD45BC). 
CD45 Isoform-specific Association with  CD4 and the  TCR. 
One possible mechanism for CD45 isoform-specific regu- 
lation after antigen stimulation is that different  CD45  iso- 
forms preferentially associate with other molecules that are 
important in TCIK signaling.  Of particular interest is an as- 
sociation  with  CD4,  since  the  CD4-associated  lck kinase 
has been identified as a potential substrate for the CD45 ty- 
rosine phosphatase.  In addition,  we have previously found 
using Th cell clones or naive and memory CD4 T  cell sub- 
sets  that CD45 isoforms reactive with an antibody specific 
for  the  B  exon  did  not  associate  with  CD4,  whereas 
"B-negative"  isoforms  did  associate  (17).  These  studies 
were difficult to interpret because both Th clones and na- 
ive and memory CD4 T  cells each express multiple  CD45 
isoforms, and the presence of the B  exon does not discrim- 
inate  between  single-,  double-,  or triple-exon-expressing 
isoforms.  To precisely identify any preferential  CD45  iso- 
form association with CD4, we have developed a cocapping 
assay  using a video laser  cytometer able  to simultaneously 
analyze cells  labeled  with both FITC- and PE-conjugated 
antibodies.  CD4 expressed on cells transfected with the dif- 
ferent  CD45  isoforms  was  induced  to  cap  by  treatment 
with  biotinylated  anti-CD4  and  PE-streptavidin,  and  the 
presence of CD45 (or CD3 as a positive control) associated 
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Figure 2.  The ability to  respond to antigen- 
specific stimulation directly correlates with  the 
size of the CD45 isoform. (A) Cells expressing  ei- 
ther  CD45Null  or CD45ABC  were  stimulated 
with  CA peptide  plus mitomycin  C-treated T 
depleted splenocytes (open circles) or with plate- 
bound  anticlonotypic  TCtk  (solid circles). After 
48 h, the supernatants were collected and tested 
for the presence of IL-2 using the IL-2-depen- 
dent cell line CTLL. (B) Summary of antigen re- 
sponsiveness of BW cells transfected with differ- 
ent CD45 isoforms. The maximum response to 
antigen stimulation is presented as a percent  of 
the maximal response to plate-bound anti-TCR 
antibody for each individual cell line. The results 
from three independent experiments (solid circles) 
are shown for each cell line. 
with the CD4  "cap" was detected by labeling with fluores- 
cein-labeled anti-CD45  or anti-CD3  antibodies.  As  illus- 
trated in Figs. 3  and 4,  the association of CD45 with CD4 
was  preferentially detected on  cells expressing CD45Null, 
whereas CD45ABC was rarely found associated with CD4. 
Fig. 3 is a representative image obtained using the video la- 
ser cytometer where fluorescence intensity is depicted on a 
pseudocolor  scale  ranging  from  dark  blue  (low  fluores- 
cence)  to white  (high fluorescence). The panel on the left 
represents the level offluorescein labeling, and the panel on 
the right represents PE labeling of the same cells. Controls 
were included to show the cells in which capping is not in- 
duced, and cells were labeled with a single fluorochrome to 
ensure that PE fluorescence (in this case) was not detected 
by the fluorescein detector. The bottom half of the figure 
demonstrates association of CD45  with the cap of CD4  in 
cells  beating  CD45Null  and  lack  of association  in  cells 
beating the CD45ABC isoform. These results are represen- 
tative  of  11  independent  experiments.  When  the  entire 
panel of cells transfected with different CD45  isoforms was 
analyzed for  colocalization in  a  quantitative  manner  (Fig. 
4),  we found  that  the  association of CD45  and  CD4  was 
directly correlated with the size of the CD45  isoform (Fig. 
4  A),  in  parallel with  their ability to  respond to  antigen- 
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specific stimulation. As an internal control, all the cell lines 
were  equivalent  in  the  ability of CD3  to  associate  with 
CD4, which was independent of the CD45 isoform (Fig. 4 
B) and occurred in CD45-  cells (latter data not shown). 
Since  CD3  is  found  associated  with  capped  CD4,  it 
seems likely that cells bearing low molecular weight CD45 
isoforms would demonstrate association with  the TC1L in 
addition to CD4.  Therefore,  the association of CD45  iso- 
forms with the TCIL complex was also examined (Fig. 5). 
The TCR  complex of BW cells expressing either CD45Null 
or CD45ABC was induced to cap, and as seen with CD4, 
the low molecular weight CD45  isoform (CD45Null)  was 
found  to  preferentially associate with  the  TCIL  complex 
compared with the higher molecular weight CD45 isoform 
(CD45ABC). These results suggest that cells expressing low 
molecular weight isoforms can more readily form a trimo- 
lecular complex  of CD3,  CD4,  and  CD45,  and  that  this 
may enhance the efficiency of the TCR  signaling complex. 
CD4-CD45  Association  Is  Independent  of the  CD45  and 
CD4  Cytoplasmic  Domains.  Since CD45  has been shown 
to be associated with the cytoskeleton (34),  it is important 
to determine the role of the cytoplasmic domains of CD45 
in  facilitating cocapping  with  CD4.  To  evaluate  the  re- 
quirement for the  cytoplasmic portion of CD45  for CD4 Figure 3.  CD45 isoform~pecific association with CD4. CD4 was induced to cap on BW cells transfected  with CD45ABC or with CD45Null by in- 
cubation with biotinylated anti-CD4 (GK1.5) for 30 min followed by PE~treptavidin for an additional 30 rain at 37~  The cells were then washed in 
cold PBS with azide,  incubated on ice with fluoresceinated  anti-CD45 for 30 min, and fixed with 1% paraformaldehyde.  Analysis was done using an 
ACAS 570 video laser cytometer equipped with a 200-roW argon laser. Red and green fluorescence  were detected using a dichroic 575-nm short-pass 
filter followed by 605-nm long-pass filter for PE detection and a 530-nm band-pass filter for FITC detection. Compensation parameters  were determined 
with cells labeled with a single fluorochrome. The data are presented as a pseudocolor image with gradations in color indicating changes in fluorescent in- 
tensity. The arrows indicate the regions on the ceil where capping occurred. 
coassociation  to  occur,  or  to  determine  if the  extracellular 
domains  are  sufficient to  mediate  isoform-specific  associa- 
tion,  additional  experiments  were  done  with  heterochi- 
meric forms of CD45  in which  the extracellular portion of 
CD45  was ligated with the GPI anchorage ofThy-1  (GPI- 
linked  CD45)  (Fig.  6  A).  As  shown  in  Fig.  6  B,  these ex- 
periments demonstrate that the ability of CD45  to colocal- 
ize  is  primarily  dictated  by  the  extracellular  domains  of 
CD45,  since  the  GPI-linked  null  isoform  cocapped  with 
CD4  as  well  as  the  wild-type  transmembrane  CD45NuU, 
whereas  the  GPI-linked  ABC  isoform,  like  its  wild-type 
counterpart,  did  not  demonstrate  significant  cocapping. 
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Figure  4.  The ability of CD45 
to  associate with  CD4  is directly 
correlated with the size of the vari- 
able  external  domain  of CD45. 
The  BW  transfectants were  ana- 
lyzed for CD45 (A) or CD3 asso- 
ciation (B) with capped CD4 using 
the  video  laser cytometer  as  de- 
scribed in Fig. 3.  The percentage 
of capped cells that demonstrated 
CD45 or CD3 association  was de- 
termined.  The  data represent the 
average plus SD of two  indepen- 
dent experiments in which at least 
50 capped cells were analyzed for 
each cell line. 
Despite association between CD45  and  CD4  on the GPI- 
linked  null  transfectant,  this  cell line  did  not  respond  to 
antigen  stimulation  (Fig.  6  C).  These  data  emphasize  the 
importance of the  CD45  tyrosine phosphatase domains in 
addition  to  the  presence  of CD45  low  molecular weight 
isoforms  in  generating  efficient  TCR  signal  transduction 
after physiologic stimulation with peptide and APC. 
Since CD45 has also been demonstrated to associate with 
lck  (35),  we  have  done  similar  cocapping  analysis  on 
CD45Null  BW  cells  that  express  mutant  and  truncated 
forms  of  CD4  (MCA,  cytoplasmic  Cys-Ala  mutation, 
which does not allow lck association; CD4-Ti, cytoplasmic 
tail deletion) to determine the influence of CD4-associated 
lck on the CD45-CD4  association (Fig. 7 A). These exper- 
iments showed that CD4-CD45  association occurred inde- 
pendently of CD4-1ck association and in the absence of the 
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Figure 5.  CD45Null preferentially colocalizes  with the TCR complex. 
The TCR complex was induced  to cap on BW cells transfected with 
CD45ABC  or CD45Null  with biotinylated clonotypic antibody to the 
D10 TCR (3D3) for 30 min followed by PE-SA for an additional 15 rain. 
The cells were then labeled with fluorescein-labeled anti-CD45 or anti- 
CD3 and analyzed for CD45 or CD4 association with the TCR cap as 
described in Fig. 3. 
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cytoplasmic domain of CD4.  In addition, we determined if 
the transmembrane domain of CD4 was required for colo- 
calization using the 4/8/4  mutant  (transmembrane portion 
of CD8  in place of CD4).  This cell line also demonstrated 
cocapping with  CD45  similar to  the  wild-type CD4  cell 
line  (Fig.  7  A),  providing  further  evidence  that  CD4- 
CD45  coassociation is  regulated  by  the  extracellular do- 
mains of both CD4 and CD45.  Control experiments using 
cells transfected with  CD8ot  instead of CD4  demonstrate 
the  specificity of the  CD4-CD45Null  interaction,  since 
capped CD8er  failed to significantly associate with  CD45- 
Null (data not shown). 
We have also used the CD4  mutants to examine the re- 
quirements of CD4-associated lck for IL-2 production after 
antigen-specific stimulation. As shown in Fig. 7 B, the lck- 
binding mutant  of CD4  (MCA mutant)  is not able to  re- 
constitute antigen-specific signaling in the BW  cells com- 
pared  with  wild-type  CD4.  This  is  consistent  with  the 
model that association of CD4 and CD45 may enhance ac- 
cess of CD4-associated lck to the tyrosine phosphatase do- 
mains  of CD45,  which  in  turn  may dephosphorylate the 
COOH-terminal  negative  regulatory site  of lck,  thus  in- 
creasing kinase activity. 
Discussion 
Although  it  is  clear  that  the  tyrosine  phosphatase  do- 
mains of CD45  play an important role in T  cell develop- 
ment  and  activation,  the  potential  role  of  the  variable 
ectodomains of CD45 in the regulation of T  cell activation 
has been  elusive.  In this report we  provide evidence that 
CD45 isoform~specific regulation of CD4 T  cell activation 
is determined by the  size  of the variable extracellular do- 
main of CD45  and correlates with the ability of CD45  to 
colocalize with CD4 and the TCR  complex. The associa- 
tion of CD45 with other molecules important in TCR  sig- 
naling may be important for the generation of optimal sig- 
nal  transduction.  Other  investigators  have  shown  that 
heterochimeric forms  of CD45  that  contain  the  cytoplas- CD45-FITC 
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Figure 6.  Preferential  cocapping  of the CD45Null isoform with CD4 is independent of the cytoplasmic  domain of CD45, although the PTPase do- 
mains are required for IL-2 production after antigen stimulation.  (./t) GPI-linked CD45Null and CD45ABC transfectants  were labeled  with anti-CD45 
antibodies  before and after treatment  with PI-PLC, and CD45 expression  was determined  by flow cytometry. (B) GPI-linked CD45NuLI and ABC trans- 
fectants were analyzed  for CD4 cocapping  compared with the intact CD45Null transfectant  as described in Fig. 3. The results represent the average and 
SD of the percentage of cocapped cells  from two independent experiments. (C) The GPI-Null transfectant  was analyzed  for antigen-specific  stimulation 
compared with the wild-type CD45Null cell line. The results are normalized  for the maximal  IL-2 production of each cell line by plate-bound  anti-TCtL 
antibody as described in Fig. 2. 
mic CD45 PTPase domains but express a different external 
domain are able to reconstitute TCR  signaling in CD45- 
(3,  5). One interpretation of these studies is that the extra- 
cellular domains of CD45 are not required for TCtL signal- 
ing. It should be noted, however, that T  cell stimulation in 
these studies was done using anti-TCtL antibodies, and we 
also  do  not find any isoform regulation of signaling using 
anti-TCR  antibodies  (Fig.  1,  reference  14).  CD45  iso- 
form--specific regulation is only observed after stimulation 
with specific antigen, which is presumably a lower potency 
signal  involving fewer  antigen  receptors  than  antibody- 
mediated TCtL stimulation. 
The ability of CD45Null and CD4 to associate was inde- 
pendent  of both  the  cytoplasmic  domains  of  CD4  and 
CD45, indicating that the association is primarily regulated 
by the extracellular domains of CD45, however, the struc- 
tural basis for this interaction is  not certain. Electron mi- 
crographs of purified CD45ABC suggest that it exists as an 
extended  rodlike  structure,  whereas  CD45Null  may  be 
more globular in form, which may promote enhanced ac- 
cess  to  other surface  antigens on the  T  cell  (36).  In BW 
ceils transfected with CD8cx and CD45Null, minimal levels 
of association  (15%)  between  CD45  and  CD8  are  seen, 
suggesting that  CD45Null does  not associate  nonspecifi- 
cally with  other  surface  antigens and  that  the  association 
with  CD4  and  the  TCI<  is  relatively specific.  Previous 
studies from our laboratory also suggest that the association 
between CD4 and CD45 is relatively specific, since CD45 
failed to associate with class I MHC and LFA-1 (17).  How- 
ever,  we  cannot rule  out  that  CD45Null  may  associate 
with other molecules on the surface of the T  cell in addi- 
tion to CD4 and the TCP-,, nor can we exclude the possi- 
bility that the interaction with the CD4--TCP,, complex is 
mediated indirectly by other molecules. Finally, it should 
also be noted that  although the  experiments presented in 
this  report  focus  on  the  association of CD45  in cis  with 
other molecules on the surface of the T  cell, they do not 
rule out the possibility that there are additional associations 
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Figure 7.  Coassociation  of CD4 
with CD45Null does not require 
CD4-1ck association or the  CD4 
transmembrane  and  cytoplasmic 
domains, although CD4-1ck asso- 
ciation is required for antigen-spe- 
cific stimulation of the CD45Null 
transfectant. (A)  CD45Null-bear- 
ing  cells transfected  with  the 
CD4Ti- (cytoplasmic tail mutant), 
MCA- (lck-binding mutant), and 
4/8/4- (contains CD8 transmem- 
brane  region) mutant forms of 
CD4 were analyzed for cocapping 
as in Fig. 3 compared with wild- 
type  CD4  on  CD45Null-  and 
CD45ABC-bearing cells. The re- 
suits represent the average and SD 
of the percentage of cocapped cells 
from two independent experiments. (B) The CD45Null/CD4-MCA  mutant was analyzed for antigen-specific stimulation compared with CD45Null/ 
wild-type CD4 and CD45NulI/CD4-  cells as described in Fig. 2. 
in trans with APC or other accessory ceils  that may further 
modify substrate access to CD45 and T  cell activation. 
Regardless of the structural basis  for the coassociation of 
low  molecular  weight  isoforms  of CD45  with  the  TCR 
complex, these results support a model by which the CD45 
extracellular  domains  can  control  the  physical  configura- 
tion of molecules around the TCR. This may result in dif- 
ferential substrate  access to the CD45 PTPase domains de- 
pending on the CD45 isoform,  thus altering proximal and 
downstream signaling events.  In support of this hypothesis 
is the  observation of Maroun  et al.  (37)  that cross-linking 
with anti-CD45 antibodies has differential inhibitory effects 
on TCR  signaling in CD4 T  cells, which primarily express 
low molecular weight isoforms (single or null exon forms), 
versus CD8 T  cells,  which primarily express high molecu- 
lar  weight  isoforms.  Thus  anti-CD45  cross-linking  may 
prevent  association  with  the  TCR  complex  in  CD4  T 
cells,  but  would  not  affect  signaling  in  CD8  T  cells  in 
which CD45 and coreceptor-TCR complex are not usu- 
ally associated. 
Our results (this report and reference  14)  and the data of 
Ong et al.  (15) support the idea that low molecular weight 
isoforms of CD45  enhance  the  efficiency of TCR  signal- 
ing,  and  we  suggest  that  differential  association  of CD45 
isoforms with the TCR  complex may explain these results. 
The mechanism by which this occurs may be complex, but 
one  model  that  is  consistent  with  the  data  is  that  during 
CD4-dependent  stimulation  of the  TCR,  low  molecular 
weight  isoforms of CD45  may have preferential  access  to 
the  CD4-associated  lck  kinase,  increasing  kinase  activity 
and  enhancing the  efficiency of TCR  signal transduction. 
In  addition  to  lck,  several  other  molecules  important  in 
TCR  signaling have been identified  as potential  substrates 
for CD45, including the tyrosine kinases fyn, ZAP-70, and 
the { chain of the TCR  (38-41). Similarly to lck, fyn is a src 
family tyrosine kinase with a negative regulatory COOH- 
terminal  tyrosine phosphorylation site that can be dephos- 
phorylated  by CD45,  thus  increasing  kinase  activity,  and 
like  lck  may have  a  role  in  enhancing  TCR  signaling  in 
vivo when CD45 is part of the TCR  complex. A  compli- 
cation of this model is that in contrast to lck and fyn, de- 
phosphorylation of the ~ chain by CD45 may have a nega- 
tive  effect on TCR  signal transduction  by preventing the 
association  of ZAP-70, which appears  to be an important 
step  in  T  cell  activation  (42,  43).  Interestingly,  decreased 
phosphorylation  of ~  and  lack  of ZAP-70  association  is 
characteristic  of TCR  signaling by altered  peptide  ligands 
(44, 45) and may reflect an alteration in the balance of the 
effect of CD45 on lck/fyn activation versus ~ and ZAP-70. 
Although the precise mechanism that regulates these appar- 
ently constrasting effects of CD45 on T  cell activation re- 
mains  unclear,  a  model  in  which  different  isoforms  of 
CD45  may affect the  molecular composition of the  TCR 
complex  and  may  differentially  affect  signaling  pathways 
provides a possible framework for understanding the differ- 
ences in  the  downstream  consequences of TCR  signaling 
during maturation in the thymus, as well as during differen- 
tiation in the periphery after antigen stimulation. 
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